Clinical significance of the use of “Cytoflavin” in premature newborns for correction of metabolic disturbances

The research of efficiency of the use Cytoflavin in neuroprotectory therapy with the aim of correction of metabolic disturbances has been carried out in a very low and extremely low birth weight neonates (n=20). A study group consisted of 10 infants taking Cytoflavin, 2 ml\kg\day, during the first 5 days of life; 10 premature neonates from a control group had basic therapy. The use of Cytoflavin within the first hours of life promoted the normalization of gas composition of blood and acid-base balance.